#4 Delirium w/ Dr Wes Ely
What is consciousness? Plum and Posner define this as Arousal & Content
Arousal: “Arousal Assessment” – i.e. the RASS (Richmond Agitation & Sedation Scale)
b. Content: “Delirium Tool” – i.e. CAM-ICU (see below)
We use both RASS & CAM-ICU to assess arousability & likelihood of delirium
These tools can be used anywhere in the hospital, in modified versions – they are not unique to the ICU!
What is delirium?
Global brain dysfunction… trillions of neurons, trillions of glial cells not functioning correctly
Phenotypically: inability to maintain attention (inattentiveness)
Test: CASABLANCA, SAVEAHAART, etc… see if patient can listen to what you are saying & squeeze or blink when the letter “A” is stated
May have hallucinations, disorganized thought
A form of organ dysfunction independently associated with mortality, increased length of stay and increased incidence of dementia / long-term disability.
Rates of delirium across ICUs
~70% in intubated patients
~40% in non-intubated patients
Approaching delirium in the critically ill
Delirium is associated with a reduction in brain volume
Follow the “Dr. Dre” or “DR-DR-E”
DR = Disease Remediation – how can I cure or otherwise mitigate the effects of the underlying disease process
Treat pain
Treat hypoxemia/hypoxia
Improve perfusion
DR = Drug Removal – what drugs are contributing to this patient’s delirium or risk for delirium
Excessive sedatives or analgesics?
Un-necessary antipsychotics?
Medications with untoward side effects?
Polypharmacy?
E = Environment – What can be added or removed from the patient’s surroundings to improve their delirium or mitigate their risk for delirium?
Glasses?
Hearing Aids?
Incorporate family whenever possible!!
Family can provide an element of therapy that we simply cannot!
Facilitate diurnal variation (lights, TV, radio, activity during the day vs darkness, quiet, etc. at night)
The A-F Bundle
An approach to ICU liberation that has been validated in over 20,000 patients which, per SCCM
Decreases likelihood of hospital death within seven days by 68%
Reduces delirium an coma days by 25-50%
Cuts ICU readmissions by 50%
Reduces discharges to nursing and rehab facilities by 40%
What is the A-F Bundle?
Assess, Prevent & Manage Pain
Consider whether pain is being effectively managed, what should be added, what can be removed
Both spontaneous awakening trials and spontaneous breathing trials
Wake up and breathe!
Choice of analgesia and sedation
Avoiding overuse of sedatives & GABAergic drugs
Delirium: assess, prevent & manage
Assess the CAM-ICU & run the “Dr. Dre”
Early mobility & exercise
Get your patients moving! There is data to support this!
Family engagement and empowerment
Again – family needs to be involved, and can provide an element of treatment that we simply cannot provide as doctors, nurses, therapists, etc.
Nuts & Bolts
Patients that are admitted to the ICU and receive RSI drugs (paralytics, sedatives, etc.) and are initially placed on the ventilator are at the “arc” of their illness
This is the time to start thinking about what medications or interventions can be removed in the next 24 hours!
Example: stop a sedative or analgesic, if it works out great – if not restart at half the dose!
“If you aren’t escalating care… you should be deescalating.”
What medications can you reach for to “treat” delirium?
MIND-USA (2018)- Haloperidol vs Ziprasidone vs Placebo for Delirium Treatment in Critical Illness: Neither the atypical or typical anti-psychotic outperformed placebo
AID-ICU (2022): Treatment of delirium in the ICU with haloperidol did not improve number of days alive and out of the hospital at 90 days versus placebo, however, there was a non-statistically significant trend identified with respect to mortality that favored the use of haloperidol
Unfortunately, there is no data that suggests antipsychotics reduce the duration of brain dysfunction (i.e. delirium) in these patient populations
Hyperactive delirium: anti-pyschotics or an alpha-2-agonist can be helpful when a patient poses a threat to themselves or others
These drugs don’t suppress the respiratory drive – okay to use with non-invasive positive-pressure ventilation
Alpha-2-agonists: dexmedetomidine, guanfacine, clonidine
Dexmedetomidine:
Signals for preventing/reducing delirium in elderly patients undergoing non-cardiac surgery and or those in the ICU
DahLIA: Use as an adjunct to standard care resulted in more ventilator-free hours at 7 days in patients on mechanical ventilation in the intensive care unit
Additional data from over a decade ago supports the use of this agent for severe alcohol withdrawal in the ICU
Anti-psychotics: haloperidol (typical), ziprasidone (atypical), quetiapine (atypical)
Use the lowest dose, know why you are doing it, and how/when you are going to stop the agent
Pain in the critically ill
Opioids are associated with increasing an incidence of delirium
However, this does NOT cross-over into the burn intensive care unit
Consider NSAIDs, acetaminophen, lidocaine patches, nerve blocks, epidurals when appropriate
Non-pharmacologic interventions
Consider eye-covers and/or ear-covers (after checking with the patient, family!)
Follow Dr. Ely: @WesElyMD on Twitter & TikTok!
See the complete infographic below:
Audio
Video
-
2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (the PADIS Guidelines from SCCM)
The Diagnosis of Stupor and Coma. Plum and Posner.
VoiceLove: A messaging app that provides HIPAA compliant communication between patients, love ones, facility staff and clergy in a medical setting.
SCCM: ICU Liberation Bundle (A2F)
Effect of early mobilization on long-term cognitive impairment in critical illness in the USA: an RCT Lancet Respiratory Medicine, 2023
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness (MIND-USA TRIAL), NEJM 2018
Haloperidol for the Treatment of Delirium in ICU Patients (AID-ICU Trial) NEJM 2018
Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial, AJRCCM 2018
Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial (DahLIA Trial) JAMA 2016
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU, Annals of Intensive Care 2012
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study, Lancet Respiratory Medicine 2021
Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults, Critical Care Medicine 2019
Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness, Lancet Respiratory Medicine 2023
-
-
Critical Illness, Brain Dysfunction, & Survivorship Center (CIBS Center)
Read Wes Ely’s Book: Every Deep Drawn Breath